Côd QR

Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan

This open-label, uncontrolled, single-arm, multicenter, phase 3 study evaluated the efficacy and safety of incobotulinumtoxinA in Japanese patients with blepharospasm. Eligible patients received incobotulinumtoxinA injections at fixed doses (50, 75, or 100 units [U] for those who had previously rece...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Toshiaki Goseki, Yoshihito Mochizuki, Akiko Masuda, Motohiro Kiyosawa, Ryosuke Miyamoto, Masato Wakakura, Akiko Yamagami, Yohei Mukai, Akihiro Shinkai, Mutsumi Iijima, Kousuke Baba, Hideki Chuman, Masahiro Hashizuka, Shohei Tateishi, Akiko Kimura
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2026-02-01
Cyfres:Toxins
Pynciau:
blepharospasm
botulinum toxin
dystonia
East Asia
efficacy
incobotulinumtoxinA
Mynediad Ar-lein:https://www.mdpi.com/2072-6651/18/2/109
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg